VC
Vivo Capital’s Ascendis Pharma ASND Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-146,025
| Closed | -$15.1M | – | 49 |
|
2022
Q3 | $15.1M | Hold |
146,025
| – | – | 1.66% | 17 |
|
2022
Q2 | $13.6M | Sell |
146,025
-296,477
| -67% | -$27.6M | 1.36% | 19 |
|
2022
Q1 | $51.9M | Hold |
442,502
| – | – | 3.58% | 7 |
|
2021
Q4 | $59.5M | Sell |
442,502
-318,104
| -42% | -$42.8M | 3.59% | 8 |
|
2021
Q3 | $121M | Sell |
760,606
-765,753
| -50% | -$122M | 5.44% | 6 |
|
2021
Q2 | $201M | Sell |
1,526,359
-137,883
| -8% | -$18.1M | 8.69% | 3 |
|
2021
Q1 | $214M | Sell |
1,664,242
-133,503
| -7% | -$17.2M | 7.54% | 4 |
|
2020
Q4 | $300M | Hold |
1,797,745
| – | – | 13.38% | 2 |
|
2020
Q3 | $277M | Hold |
1,797,745
| – | – | 16.03% | 1 |
|
2020
Q2 | $266M | Sell |
1,797,745
-205,402
| -10% | -$30.4M | 19.06% | 1 |
|
2020
Q1 | $226M | Buy |
+2,003,147
| New | +$226M | 20.43% | 1 |
|
2019
Q3 | – | Sell |
-2,060,135
| Closed | -$237M | – | 10 |
|
2019
Q2 | $237M | Buy |
2,060,135
+13,303
| +0.6% | +$1.53M | 22.23% | 1 |
|
2019
Q1 | $241M | Sell |
2,046,832
-120,000
| -6% | -$14.1M | 24.02% | 1 |
|
2018
Q4 | $136M | Hold |
2,166,832
| – | – | 17.34% | 1 |
|
2018
Q3 | $154M | Hold |
2,166,832
| – | – | 15.48% | 1 |
|
2018
Q2 | $144M | Hold |
2,166,832
| – | – | 18.57% | 1 |
|
2018
Q1 | $142M | Buy |
2,166,832
+400,000
| +23% | +$26.2M | 20.07% | 2 |
|
2017
Q4 | $70.8M | Hold |
1,766,832
| – | – | 15.16% | 1 |
|
2017
Q3 | $64M | Hold |
1,766,832
| – | – | 12.94% | 3 |
|
2017
Q2 | $49M | Hold |
1,766,832
| – | – | 12.35% | 3 |
|
2017
Q1 | $49.5M | Hold |
1,766,832
| – | – | 14.55% | 2 |
|
2016
Q4 | $35.8M | Hold |
1,766,832
| – | – | 11.78% | 2 |
|
2016
Q3 | $35.5M | Hold |
1,766,832
| – | – | 11.07% | 2 |
|
2016
Q2 | $23.4M | Buy |
1,766,832
+347,500
| +24% | +$4.61M | 6.4% | 5 |
|
2016
Q1 | $26.3M | Buy |
+1,419,332
| New | +$26.3M | 6.6% | 6 |
|